{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T18:31:30Z","timestamp":1781375490464,"version":"3.54.1"},"reference-count":163,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Fondi di Ateneo Sapienza"},{"DOI":"10.13039\/501100000783","name":"REA","doi-asserted-by":"publisher","award":["624341"],"award-info":[{"award-number":["624341"]}],"id":[{"id":"10.13039\/501100000783","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.bbadis.2016.07.005","type":"journal-article","created":{"date-parts":[[2016,7,17]],"date-time":"2016-07-17T00:56:31Z","timestamp":1468716991000},"page":"1871-1882","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Aberrant protein phosphorylation in Alzheimer disease brain disturbs pro-survival and cell death pathways"],"prefix":"10.1016","volume":"1862","author":[{"given":"M.","family":"Perluigi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2013-209X","authenticated-orcid":false,"given":"F.","family":"Di Domenico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.","family":"Butterfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2016.07.005_bb0005","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nn.4018","article-title":"Three dimensions of the amyloid hypothesis: time, space and \u2018wingmen\u2019","volume":"18","author":"Musiek","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0010","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0166-2236(98)01337-X","article-title":"Tau protein pathology in neurodegenerative diseases","volume":"21","author":"Spillantini","year":"1998","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0015","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1042\/BST0380967","article-title":"From tau phosphorylation to tau aggregation: what about neuronal death?","volume":"38","author":"Buee","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0020","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.freeradbiomed.2012.02.034","article-title":"p53 at the crossroads between cancer and neurodegeneration","volume":"52","author":"Lanni","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0025","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.cell.2010.12.001","article-title":"A tissue-specific atlas of mouse protein phosphorylation and expression","volume":"143","author":"Huttlin","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neubiorev.2014.06.012","article-title":"Synapses, spines and kinases in mammalian learning and memory, and the impact of aging","volume":"50","author":"van der Zee","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0035","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1101\/lm.028449.112","article-title":"The roles of protein kinases in learning and memory","volume":"20","author":"Giese","year":"2013","journal-title":"Learn. Mem."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0040","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1017\/S1461145710001537","article-title":"From understanding synaptic plasticity to the development of cognitive enhancers","volume":"14","author":"Cheung","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0045","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nrn3486","article-title":"Molecular mechanisms of dendrite stability","volume":"14","author":"Koleske","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.arr.2012.06.008","article-title":"Tau protein phosphatases in Alzheimer's disease: the leading role of PP2A","volume":"12","author":"Martin","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0055","doi-asserted-by":"crossref","first-page":"6584","DOI":"10.1021\/ja0126576","article-title":"Solid-phase synthesis and biochemical studies of O-boranophosphopeptides and O-dithiophosphopeptides","volume":"124","author":"Jenkins","year":"2002","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0060","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1742-4658.2012.08655.x","article-title":"Protein tyrosine phosphatase structure-function relationships in regulation and pathogenesis","volume":"280","author":"Bohmer","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0065","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1517\/13543776.2013.768985","article-title":"PTEN modulators: a patent review","volume":"23","author":"Boosani","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0070","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/B978-0-12-396456-4.00012-2","article-title":"Protein phosphatases and Alzheimer's disease","volume":"106","author":"Braithwaite","year":"2012","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0075","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/alzrt238","article-title":"Fyn kinase inhibition as a novel therapy for Alzheimer's disease","volume":"6","author":"Nygaard","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0080","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s00018-010-0616-z","article-title":"From axon-glial signalling to myelination: the integrating role of oligodendroglial Fyn kinase","volume":"68","author":"Kramer-Albers","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0085","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.cellbio.13.1.513","article-title":"Cellular functions regulated by Src family kinases","volume":"13","author":"Thomas","year":"1997","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0090","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00001756-199304000-00024","article-title":"The protein tyrosine kinase, fyn, in Alzheimer's disease pathology","volume":"4","author":"Shirazi","year":"1993","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0095","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","article-title":"Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins","volume":"95","author":"Lambert","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0100","doi-asserted-by":"crossref","first-page":"467","DOI":"10.5483\/BMBRep.2009.42.8.467","article-title":"Aberrant phosphorylation in the pathogenesis of Alzheimer's disease","volume":"42","author":"Chung","year":"2009","journal-title":"BMB Rep."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-1-59745-562-6_8","article-title":"Proteomic analysis of protein phosphorylation and ubiquitination in Alzheimer's disease","volume":"566","author":"Thomas","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0110","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1038\/onc.2012.640","article-title":"Senescence and aging: the critical roles of p53","volume":"32","author":"Rufini","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049846","article-title":"Lack of p53 affects the expression of several brain mitochondrial proteins: insights from proteomics into important pathways regulated by p53","volume":"7","author":"Fiorini","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0120","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.mp.4002060","article-title":"Conformationally altered p53: a novel Alzheimer's disease marker?","volume":"13","author":"Lanni","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fendo.2015.00013","article-title":"Insulin, aging, and the brain: mechanisms and implications","volume":"6","author":"Akintola","year":"2015","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0130","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.bbadis.2014.06.010","article-title":"Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain","volume":"1842","author":"Butterfield","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0135","series-title":"Posttranslational Modification of Proteins: Expanding Nature's Inventory","author":"Walsh","year":"2006"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0140","doi-asserted-by":"crossref","first-page":"E127","DOI":"10.1038\/ncb0502-e127","article-title":"The origins of protein phosphorylation","volume":"4","author":"Cohen","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1021\/cb900277e","article-title":"Phosphoproteomics for the masses","volume":"5","author":"Grimsrud","year":"2010","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0150","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1039\/b905580k","article-title":"Phosphoproteomics\u2014finally fulfilling the promise?","volume":"5","author":"Rogers","year":"2009","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0155","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cbpa.2009.06.022","article-title":"The phosphoproteomics data explosion","volume":"13","author":"Lemeer","year":"2009","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0160","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/pmic.200700697","article-title":"Phosphoproteomic analysis of Leishmania donovani pro- and amastigote stages","volume":"8","author":"Morales","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0165","first-page":"33","article-title":"Phosphoproteomic analysis of aged skeletal muscle","volume":"22","author":"Gannon","year":"2008","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0170","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jprot.2011.03.033","article-title":"Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects","volume":"74","author":"Di Domenico","year":"2011","journal-title":"J. Proteome"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0175","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s10571-009-9358-6","article-title":"New age of neuroproteomics in Alzheimer's disease research","volume":"29","author":"Kovacech","year":"2009","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0180","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/pmic.201200415","article-title":"Phosphoproteome analysis of an early onset mouse model (TgCRND8) of Alzheimer's disease reveals temporal changes in neuronal and glia signaling pathways","volume":"13","author":"Wang","year":"2013","journal-title":"Proteomics"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0185","doi-asserted-by":"crossref","first-page":"16755","DOI":"10.1523\/JNEUROSCI.4521-10.2010","article-title":"Reimagining Alzheimer's disease\u2014an age-based hypothesis","volume":"30","author":"Herrup","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0190","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/archneur.1995.00540250089017","article-title":"Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease","volume":"52","author":"Bierer","year":"1995","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0195","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.brainres.2011.07.052","article-title":"Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease","volume":"1415","author":"Reddy","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/biom6020021","article-title":"New features about tau function and dysfunction","volume":"6","author":"Medina","year":"2016","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0205","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.neuron.2011.04.009","article-title":"The many faces of tau","volume":"70","author":"Morris","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0210","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nm.2613","article-title":"Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export","volume":"18","author":"Lei","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0215","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1523\/JNEUROSCI.2842-14.2015","article-title":"Tau phosphorylation at serine 396 residue is required for hippocampal LTD","volume":"35","author":"Regan","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0220","doi-asserted-by":"crossref","first-page":"16482","DOI":"10.1523\/JNEUROSCI.3418-14.2014","article-title":"Tau-mediated NMDA receptor impairment underlies dysfunction of a selectively vulnerable network in a mouse model of frontotemporal dementia","volume":"34","author":"Warmus","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0225","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1523\/JNEUROSCI.3191-12.2013","article-title":"Tau loss attenuates neuronal network hyperexcitability in mouse and Drosophila genetic models of epilepsy","volume":"33","author":"Holth","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0230","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models","volume":"142","author":"Ittner","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0235","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1073\/pnas.82.12.4274","article-title":"Aberrant neurofilament phosphorylation in Alzheimer disease","volume":"82","author":"Sternberger","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0240","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0169-328X(94)90081-7","article-title":"Microtubule-associated protein MAP1B showing a fetal phosphorylation pattern is present in sites of neurofibrillary degeneration in brains of Alzheimer's disease patients","volume":"26","author":"Ulloa","year":"1994","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0245","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/00001756-200003200-00042","article-title":"Phosphorylation of MARCKS in Alzheimer disease brains","volume":"11","author":"Kimura","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0250","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.bbadis.2014.04.007","article-title":"Neuropathological role of PI3K\/Akt\/mTOR axis in Down syndrome brain","volume":"1842","author":"Perluigi","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0255","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000067425","article-title":"Role of serine\/threonine protein phosphatase in Alzheimer's disease","volume":"11","author":"Tian","year":"2002","journal-title":"Neurosignals"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0260","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0002-9440(10)62486-8","article-title":"Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease","volume":"166","author":"Tanimukai","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0265","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnins.2015.00204","article-title":"Aberrant insulin signaling in Alzheimer's disease: current knowledge","volume":"9","author":"Bedse","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0270","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.freeradbiomed.2015.12.012","article-title":"Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: a new paradigm","volume":"91","author":"Barone","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0275","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.2353\/ajpath.2009.090157","article-title":"Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: implication for Alzheimer's disease","volume":"175","author":"Deng","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0280","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1471-4159.2009.06320.x","article-title":"Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease","volume":"111","author":"Liu","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0285","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1021\/pr800667a","article-title":"Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD","volume":"8","author":"Owen","year":"2009","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0290","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1002\/jnr.22528","article-title":"The wheat germ agglutinin-fractionated proteome of subjects with Alzheimer's disease and mild cognitive impairment hippocampus and inferior parietal lobule: implications for disease pathogenesis and progression","volume":"88","author":"Di Domenico","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0295","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-150417","article-title":"Quantitative phosphoproteomic analyses of the inferior parietal lobule from three different pathological stages of Alzheimer's disease","volume":"49","author":"Triplett","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0300","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.bbadis.2014.05.014","article-title":"Increased O-GlcNAc levels correlate with decreased O-GlcNAcase levels in Alzheimer disease brain","volume":"1842","author":"Forster","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0305","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1021\/pr8000496","article-title":"Phosphoproteomic analysis of human brain by calcium phosphate precipitation and mass spectrometry","volume":"7","author":"Xia","year":"2008","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0310","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/pmic.201400171","article-title":"Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteome","volume":"15","author":"Tan","year":"2015","journal-title":"Proteomics"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0315","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/hmg\/ddu475","article-title":"Comprehensive phosphoproteome analysis unravels the core signaling network that initiates the earliest synapse pathology in preclinical Alzheimer's disease brain","volume":"24","author":"Tagawa","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0320","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1096\/fj.11-181297","article-title":"Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs","volume":"25","author":"Rudrabhatla","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0325","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1096\/fj.10-157859","article-title":"Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF-M\/H) in Alzheimer's disease by iTRAQ","volume":"24","author":"Rudrabhatla","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0330","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0169-328X(02)00488-6","article-title":"Up-regulation of mitogen-activated protein kinases ERK1\/2 and MEK1\/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease","volume":"109","author":"Pei","year":"2002","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0335","doi-asserted-by":"crossref","first-page":"11711","DOI":"10.1021\/bi990200r","article-title":"General role of GDP dissociation inhibitor 2 in membrane release of Rab proteins: modulations of its functional interactions by in vitro and in vivo structural modifications","volume":"38","author":"Shisheva","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0340","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1042\/BJ20140772","article-title":"Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain","volume":"463","author":"Butterfield","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0345","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0896-6273(03)00633-0","article-title":"Cytoskeletal dynamics and transport in growth cone motility and axon guidance","volume":"40","author":"Dent","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0350","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nrm1260","article-title":"Post-translational modifications regulate microtubule function","volume":"4","author":"Westermann","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0355","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/mas.21374","article-title":"Mass spectrometry and redox proteomics: applications in disease","volume":"33","author":"Butterfield","year":"2014","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0360","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1471-4159.2012.07737.x","article-title":"Phosphoproteome profiling of substantia nigra and cortex regions of Alzheimer's disease patients","volume":"121","author":"Zahid","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0365","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/pmic.201400189","article-title":"Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins","volume":"15","author":"Dammer","year":"2015","journal-title":"Proteomics"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0370","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrm1838","article-title":"Cell-signalling dynamics in time and space","volume":"7","author":"Kholodenko","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0375","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/35037739","article-title":"Apoptosis in the nervous system","volume":"407","author":"Yuan","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0380","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.1038\/sj.onc.1207116","article-title":"Control of apoptosis by p53","volume":"22","author":"Fridman","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0385","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/sj.cdd.4400741","article-title":"The role of p53 in neuronal cell death","volume":"7","author":"Morrison","year":"2000","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0390","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1089\/ars.2011.4124","article-title":"Lack of p53 decreases basal oxidative stress levels in the brain through upregulation of thioredoxin-1, biliverdin reductase-A, manganese superoxide dismutase, and nuclear factor kappa-B","volume":"16","author":"Barone","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0395","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s13238-011-1063-9","article-title":"The impact of acetylation and deacetylation on the p53 pathway","volume":"2","author":"Brooks","year":"2011","journal-title":"Protein Cell"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0400","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1101\/gad.247452.114","article-title":"Limiting the power of p53 through the ubiquitin proteasome pathway","volume":"28","author":"Pant","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0405","doi-asserted-by":"crossref","first-page":"490","DOI":"10.18632\/aging.100047","article-title":"The regulation of p53 by phosphorylation: a model for how distinct signals integrate into the p53 pathway","volume":"1","author":"Maclaine","year":"2009","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0410","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/ars.2007.1957","article-title":"Redox regulation of cell survival","volume":"10","author":"Trachootham","year":"2008","journal-title":"Antioxid. Redox Signal."},{"issue":"Suppl. 2","key":"10.1016\/j.bbadis.2016.07.005_bb0415","first-page":"9","article-title":"P53 regulation and function in normal cells and tumors","volume":"60","author":"Liu","year":"2000","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0420","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s11064-009-9924-9","article-title":"Glutathionylation of the pro-apoptotic protein p53 in Alzheimer's disease brain: implications for AD pathogenesis","volume":"34","author":"Di Domenico","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0425","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1006\/bbrc.1997.6301","article-title":"Changes of p53 in the brains of patients with Alzheimer's disease","volume":"232","author":"Kitamura","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0430","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-510X(97)00131-7","article-title":"Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease","volume":"152","author":"de la Monte","year":"1997","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0435","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0304-3940(98)00945-8","article-title":"Apoptosis-associated proteins p53 and APO-1\/Fas (CD95) in brains of adult patients with Down syndrome","volume":"260","author":"Seidl","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0440","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-6632.1982.tb26840.x","article-title":"Down's syndrome, aging, and Alzheimer's disease: a clinical review","volume":"396","author":"Lott","year":"1982","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0445","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-151105","article-title":"Activation of p53 in Down syndrome and in the Ts65Dn mouse brain is associated with a pro-apoptotic phenotype","author":"Tramutola","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0450","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neulet.2007.03.026","article-title":"p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells","volume":"418","author":"Hooper","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0455","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1582-4934.2008.00163.x","article-title":"Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease","volume":"12","author":"Cenini","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0460","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.freeradbiomed.2008.03.015","article-title":"Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease","volume":"45","author":"Cenini","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0465","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.13","article-title":"Conformational altered p53 affects neuronal function: relevance for the response to toxic insult and growth-associated protein 43 expression","volume":"4","author":"Buizza","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0470","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000113704","article-title":"Conformationally altered p53: a putative peripheral marker for Alzheimer's disease","volume":"5","author":"Uberti","year":"2008","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0475","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.neurobiolaging.2005.06.013","article-title":"Identification of a mutant-like conformation of p53 in fibroblasts from sporadic Alzheimer's disease patients","volume":"27","author":"Uberti","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0480","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1073\/pnas.062059899","article-title":"Wild-type and mutated presenilins 2 trigger p53-dependent apoptosis and down-regulate presenilin 1 expression in HEK293 human cells and in murine neurons","volume":"99","author":"Alves da Costa","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0485","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1073\/pnas.96.13.7547","article-title":"Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis","volume":"96","author":"Xu","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0490","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1096\/fj.04-2637fje","article-title":"Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease","volume":"19","author":"Ohyagi","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0495","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neulet.2006.02.082","article-title":"TAp73alpha induces tau phosphorylation in HEK293a cells via a transcription-dependent mechanism","volume":"401","author":"Hooper","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0500","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nrm2261","article-title":"The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease","volume":"8","author":"Lu","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0505","first-page":"93","article-title":"Regulation of protein conformation by Pin1 offers novel disease mechanisms and therapeutic approaches in Alzheimer's disease","volume":"17","author":"Driver","year":"2014","journal-title":"Discov. Med."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0510","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2014.12.027","article-title":"Pin1 cysteine-113 oxidation inhibits its catalytic activity and cellular function in Alzheimer's disease","volume":"76","author":"Chen","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0515","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.neurobiolaging.2005.05.005","article-title":"Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: a redox proteomics analysis","volume":"27","author":"Sultana","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0520","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1111\/j.1471-4159.2006.03995.x","article-title":"Pin1 in Alzheimer's disease","volume":"98","author":"Butterfield","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0525","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tem.2005.01.008","article-title":"The role of insulin receptor signaling in the brain","volume":"16","author":"Plum","year":"2005","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0530","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1016\/S0021-9258(18)69163-X","article-title":"A cascade of tyrosine autophosphorylation in the beta-subunit activates the phosphotransferase of the insulin receptor","volume":"263","author":"White","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0535","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1016\/S0021-9258(18)68823-4","article-title":"Relationship of site-specific beta subunit tyrosine autophosphorylation to insulin activation of the insulin receptor (tyrosine) protein kinase activity","volume":"263","author":"Tornqvist","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroscience.2016.03.056","article-title":"The role of insulin like growth factor 1 (IGF-1) in brain development, maturation and neuroplasticity","author":"Dyer","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0545","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1111\/j.1460-9568.2006.04859.x","article-title":"Signalling mechanisms mediated by the phosphoinositide 3-kinase\/Akt cascade in synaptic plasticity and memory in the rat","volume":"23","author":"Horwood","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0550","doi-asserted-by":"crossref","first-page":"7060","DOI":"10.1073\/pnas.0909314107","article-title":"PI3 kinase signaling is involved in Abeta-induced memory loss in Drosophila","volume":"107","author":"Chiang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0555","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nrn2214","article-title":"Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity","volume":"8","author":"Calabrese","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0560","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2125.2010.03830.x","article-title":"Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?","volume":"71","author":"Akter","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0565","first-page":"841","article-title":"Antioxidant activities of bile pigments","volume":"6","author":"Stocker","year":"2004","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0570","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1111\/j.1582-4934.2008.00680.x","article-title":"Characterization of the S-denitrosylating activity of bilirubin","volume":"13","author":"Barone","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0575","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1073\/pnas.0502173102","article-title":"Human biliverdin reductase: a member of the insulin receptor substrate family with serine\/threonine\/tyrosine kinase activity","volume":"102","author":"Lerner-Marmarosh","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0580","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.tips.2008.12.003","article-title":"Pleiotropic functions of biliverdin reductase: cellular signaling and generation of cytoprotective and cytotoxic bilirubin","volume":"30","author":"Kapitulnik","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0585","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0968-0004(99)01472-3","article-title":"The PH superfold: a structural scaffold for multiple functions","volume":"24","author":"Blomberg","year":"1999","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0590","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0955-0674(99)80029-5","article-title":"Signalling through phosphoinositide 3-kinases: the lipids take centre stage","volume":"11","author":"Leevers","year":"1999","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0595","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/bj20021626","article-title":"Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm","volume":"370","author":"Newton","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0600","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12035-012-8339-9","article-title":"Insulin in the brain: sources, localization and functions","volume":"47","author":"Ghasemi","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0605","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cmet.2011.08.016","article-title":"Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation","volume":"14","author":"Belanger","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0610","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4149\/endo_2014_01_35","article-title":"Glucose transport in brain - effect of inflammation","volume":"48","author":"Jurcovicova","year":"2014","journal-title":"Endocr. Regul."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0615","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1172\/JCI64595","article-title":"Alzheimer's disease and insulin resistance: translating basic science into clinical applications","volume":"123","author":"De Felice","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0620","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1016\/j.jalz.2013.12.010","article-title":"Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease","volume":"10","author":"Ferreira","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0625","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrn4019","article-title":"Hippocampal insulin resistance and cognitive dysfunction","volume":"16","author":"Biessels","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0630","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0635","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease\u2014is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0640","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3233\/JAD-2005-8304","article-title":"Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine","volume":"8","author":"Rivera","year":"2005","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0645","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.jalz.2013.12.004","article-title":"How does brain insulin resistance develop in Alzheimer's disease?","volume":"10","author":"De Felice","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0650","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.euroneuro.2014.01.020","article-title":"Insulin and insulin-like growth factor receptors in the brain: physiological and pathological aspects","volume":"24","author":"Werner","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0655","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s007020050068","article-title":"Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease","volume":"105","author":"Frolich","year":"1998","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0660","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/1098-2396(20001215)38:4<450::AID-SYN10>3.0.CO;2-J","article-title":"Insulin-like growth factor-I and its receptor in the frontal cortex, hippocampus, and cerebellum of normal human and Alzheimer disease brains","volume":"38","author":"Jafferali","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0665","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s007020050068","article-title":"Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease","volume":"105","author":"Frolich","year":"1998","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0670","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1749-6632.1999.tb07839.x","article-title":"A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease","volume":"893","author":"Frolich","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0675","doi-asserted-by":"crossref","first-page":"RC221","DOI":"10.1523\/JNEUROSCI.22-10-j0001.2002","article-title":"Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor","volume":"22","author":"Xie","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0680","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1096\/fj.06-7703com","article-title":"Amyloid beta oligomers induce impairment of neuronal insulin receptors","volume":"22","author":"Zhao","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0685","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1073\/pnas.0308724101","article-title":"Role for neuronal insulin resistance in neurodegenerative diseases","volume":"101","author":"Schubert","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0690","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.neurobiolaging.2005.09.039","article-title":"Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer's-like neuropathology in rodents: new cues into the human disease?","volume":"27","author":"Carro","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0695","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1471-4159.2006.04368.x","article-title":"Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein","volume":"101","author":"Grunblatt","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0700","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.neuroscience.2015.06.060","article-title":"Activation of the insulin-signaling pathway in sciatic nerve and hippocampus of type 1 diabetic rats","volume":"303","author":"King","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0705","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3233\/JAD-2012-120046","article-title":"Involvement of insulin-like growth factor 1 receptor signaling in the amyloid-beta peptide oligomers-induced p75 neurotrophin receptor protein expression in mouse hippocampus","volume":"31","author":"Ito","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0710","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nn1102-1131","article-title":"The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system","volume":"5","author":"Dechant","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2016.03.011","article-title":"Reactive oxygen species mediate insulin signal transduction in mouse hypothalamus","volume":"619","author":"Onoue","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0720","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-2187-8-11","article-title":"Mitochondrial H2O2 as an enable signal for triggering autophosphorylation of insulin receptor in neurons","volume":"8","author":"Persiyantseva","year":"2013","journal-title":"J. Mol. Signal."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0725","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1089\/ars.2005.7.1014","article-title":"H2O2-induced phosphorylation of ERK1\/2 and PKB requires tyrosine kinase activity of insulin receptor and c-Src","volume":"7","author":"Mehdi","year":"2005","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0735","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1179\/1476830513Y.0000000092","article-title":"Damaging effects of a high-fat diet to the brain and cognition: a review of proposed mechanisms","volume":"17","author":"Freeman","year":"2014","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0740","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1096\/fj.03-0978fje","article-title":"Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease","volume":"18","author":"Ho","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0745","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1196\/annals.1427.024","article-title":"Regulation of forkhead transcription factor FoxO3a contributes to calorie restriction-induced prevention of Alzheimer's disease-type amyloid neuropathology and spatial memory deterioration","volume":"1147","author":"Qin","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0750","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10522-014-9519-y","article-title":"The roles of FoxOs in modulation of aging by calorie restriction","volume":"16","author":"Kim","year":"2015","journal-title":"Biogerontology"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0755","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.bbadis.2011.01.005","article-title":"Biliverdin reductase\u2014a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment","volume":"1812","author":"Barone","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0760","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1046\/j.1471-4159.1997.69031161.x","article-title":"The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins","volume":"69","author":"Subramaniam","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0765","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.freeradbiomed.2010.09.013","article-title":"Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Abeta accumulation in AD brain","volume":"49","author":"Owen","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0770","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0891-5849(02)00794-3","article-title":"Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress","volume":"32","author":"Butterfield","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0775","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1471-4159.2001.00451.x","article-title":"The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42","volume":"78","author":"Lauderback","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0780","series-title":"Advances in Cell Aging and Gerontology","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1566-3124(08)60057-7","article-title":"Protein oxidation processes in aging brain","author":"Butterfield","year":"1997"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0785","doi-asserted-by":"crossref","first-page":"6870","DOI":"10.1073\/pnas.0800750105","article-title":"Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling","volume":"105","author":"Lerner-Marmarosh","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0790","first-page":"565","article-title":"Extracellular signal regulated kinases. Localization of protein and mRNA in the human hippocampal formation in Alzheimer's disease","volume":"144","author":"Hyman","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0795","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3233\/JAD-141422","article-title":"Common mechanisms of Alzheimer's disease and ischemic stroke: the role of protein kinase C in the progression of age-related neurodegeneration","volume":"43","author":"Lucke-Wold","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0800","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1021\/cn400018y","article-title":"Translocation of PKC by yessotoxin in an in vitro model of Alzheimer's disease with improvement of tau and beta-amyloid pathology","volume":"4","author":"Alonso","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0805","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1126\/science.1200215","article-title":"Enhancement of consolidated long-term memory by overexpression of protein kinase Mzeta in the neocortex","volume":"331","author":"Shema","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2016.07.005_bb0810","doi-asserted-by":"crossref","first-page":"5906","DOI":"10.1523\/JNEUROSCI.20-16-05906.2000","article-title":"A role for the beta isoform of protein kinase C in fear conditioning","volume":"20","author":"Weeber","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0815","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2174\/15672050113106660166","article-title":"Neuron-specific mitochondrial DNA deletion levels in sporadic Alzheimer's disease","volume":"10","author":"Gerschutz","year":"2013","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bbadis.2016.07.005_bb0820","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/B978-0-12-394816-8.00008-8","article-title":"Activation of protein kinase C isozymes for the treatment of dementias","volume":"64","author":"Sun","year":"2012","journal-title":"Adv. Pharmacol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544391630165X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544391630165X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T05:16:46Z","timestamp":1656825406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092544391630165X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":163,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S092544391630165X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2016.07.005","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aberrant protein phosphorylation in Alzheimer disease brain disturbs pro-survival and cell death pathways","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2016.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}